Delta 9 Cannabis Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- John William Arbuthnot IV
- Full Time Employees
- 200
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- P.O. Box 68096 Winnipeg MB Canada R3L 2V9
- IPO Date
- Nov 6, 2017
- Website
- delta9.ca
- Similar Companies
- Business
- Delta 9 Cannabis Inc. Delta 9 Cannabis Inc. operates as a vertically integrated cannabis company in Canada, focusing on the cultivation, processing, extraction, wholesale distribution, retail sale, and medical consultation services for medical and recreational cannabis products. The company produces and sells dried cannabis flowers, pre-rolls, dried sift cannabis, oils, extracted and derivative products including high-terpene milled flower and vape cartridges under brands such as Delta 9 Cannabis, Busted Nugs, RAZL, and 770 Cannabis; it also offers proprietary cannabis grow pods and live plants to other licensed producers, operates retail stores under the Delta 9 Cannabis Store brand across Canadian provinces including Manitoba, Alberta, British Columbia, Ontario, Newfoundland, and Yukon, and exports products to Australia while providing physician consultations through Delta 9 Lifestyle Cannabis Clinic Inc. Wholly-owned subsidiary Delta 9 Bio-Tech Inc. manages production at a 95,000 square foot facility in Winnipeg, Manitoba, with supply agreements in multiple provinces and capabilities for automated bottling and rolling. Founded in 2001 and headquartered in Winnipeg, Manitoba, the company entered creditor protection under the Companies’ Creditors Arrangement Act in July 2024, facilitating a transaction where The FIKA Company acquired its cannabis retail store and logistics businesses, while Simply Solventless Concentrates Ltd. completed the acquisition of Delta 9 Bio-Tech Inc. in February 2025 through a court-approved reverse vesting order.
Delta 9 Cannabis Inc. (DLTNF) Q3 2023 Earnings Call Transcript
Delta 9 Cannabis Inc. (DLTNF) Q2 2023 Earnings Call Transcript
Delta 9 Reports Financials for Q2 2023
Delta 9 to Supply Cannabis to Northwest Territories
Delta 9 Expands Distribution Business in Manitoba
Delta 9 Provides Guidance & Timing for Q2 2023 Results
Delta 9 Cannabis secures significant purchase order for eight modular grow pods
Delta 9 Cannabis welcomes Manitoba Conservative Government's bill to repeal Social Responsibility Fee
Delta 9 Cannabis reports significant growth in net revenue for first quarter 2023
Cannabis stocks slump on SAFE Banking Act Senate hearing and mixed quarterly earnings
Delta 9 Cannabis bags Grow Pods contract from BC cannabis grower
Delta 9 Cannabis forecasts rise in Q1 revenue
Delta 9 Cannabis secures US purchase order for up to eight of its modular Grow Pods
Delta 9 Cannabis expands domestic market with Yukon supply deal
Delta 9 Cannabis reports record revenue for Q4 and full year 2022
Delta 9 Cannabis significantly increases its capacity to manufacture prerolled cannabis products
Delta 9 Cannabis ships cannabis flower to Australian customer
Delta 9 Cannabis to open 41st retail store in Winnipeg, Western Canada
Delta 9 Cannabis primes investors for higher 4Q revenues
Delta 9 Cannabis opens its fortieth retail store